MedPath

Evaluation of the Effect of Methylene Blue in the Treatment of Outpatients with COVID-19 Referred to the Lung Clinic

Phase 3
Conditions
Covid-19.
Covid-19
U07.1
Registration Number
IRCT20220211053993N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
240
Inclusion Criteria

Outpatients with COVID-19 virus referred to a Lung Clinic Confirmed by HRCT or PCR
SPO2 without Mask after Ten Minutes between 70-96
Age Over 18 Years Old

Exclusion Criteria

Pregnancy
Severe Liver and Heart Disease
Acute Renal Failure Associated with the Need for Dialysis
Glucose 6-Phosphate Dehydrogenase Deficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath